REGN : Insider Transactions for Regeneron Pharmaceuticals Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Regeneron Pharmaceuticals Inc (REGN)

$1,034.23

10.14 (0.99%) as of 4:30 Fri 7/5

Download

Exchange:

Nasdaq National Market

Security Type:

Common

Shares Out:

104,690,000

Market Cap:

108.27(B)

Last Volume:

418,302

Avg Vol:

758,271

52 Week Range:

$692.45 - $1071.19

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

	S&P COMPOSITE 1500		NASDAQ BIOTECHNOLOGY
	NASDAQ COMPOSITE		S&P SMALLCAP 600
	NASDAQ NNM COMPOSITE

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : 150

Guru Rank Value : 6.9

Guru Occurances : 2


6 Months 1 Year 2 Year

Company Profile Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	192,995	237,237	312,646	469,880
Total Sell Value	$189,656,342	$231,855,596	$295,997,978	$406,115,303
Total People Sold	7	13	16	18
Total Sell Transactions	18	40	67	129
End Date	2024-04-07	2024-01-05	2023-07-07	2022-07-07

Adjust Filter Settings

Records found: 2433

Page 76 of 98

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Chairman of the Board

• • –

2011-07-13

4

AS

$56.71

$1,482,552

I/I

(25,935)

160,658

-

Roberts William

VP Regulatory Development and

• – –

2011-07-13

4

AS

$56.71

$247,063

I/I

(4,322)

3,757

-

Chairman of the Board

• • –

2011-07-12

4

AS

$56.69

$1,353,286

I/I

(23,635)

186,593

-

Roberts William

VP Regulatory Development and

• – –

2011-07-12

4

AS

$56.67

$225,511

I/I

(3,939)

8,079

-

Chairman of the Board

• • –

2011-07-11

4

AS

$57.48

$1,431,912

I/I

(24,772)

210,228

-

Roberts William

VP Regulatory Development and

• – –

2011-07-11

4

AS

$57.48

$238,671

I/I

(4,129)

12,018

-

Goldstein Joseph L

Director

– • –

2011-07-01

4

AS

$55.91

$563,608

D/D

(10,000)

0

-

Goldstein Joseph L

Director

– • –

2011-07-01

4

OE

$28.81

$288,100

D/D

10,000

9,200

-

Brown Michael S

Director

– • –

2011-07-01

4

AS

$55.89

$1,407,041

D/D

(25,000)

14,662

-

Brown Michael S

Director

– • –

2011-07-01

4

OE

$15.80

$590,150

D/D

25,000

24,662

-

Baker Charles A

Director

– • –

2011-07-01

4

AS

$55.94

$628,472

D/D

(11,000)

5,590

-

Baker Charles A

Director

– • –

2011-07-01

4

OE

$28.81

$316,910

D/D

11,000

13,252

-

Chairman of the Board

• • –

2011-06-30

4

GD

$0.00

$0

I/I

3,798

175,056

-

Chairman of the Board

• • –

2011-06-20

4

AS

$0.00

$0

I/I

(30,778)

94,222

-

Chairman of the Board

• • –

2011-06-20

4

A

$0.00

$0

D/D

30,778

140,087

-

Goldstein Joseph L

Director

– • –

2011-05-04

4

S

$48.89

$244,450

D/D

(5,000)

0

-

Goldstein Joseph L

Director

– • –

2011-05-04

4

OE

$28.81

$144,050

D/D

5,000

5,000

-

Gilman Alfred G

Director

– • –

2011-05-02

4

AS

$50.68

$1,015,460

D/D

(20,000)

11,875

-

Gilman Alfred G

Director

– • –

2011-04-29

4

A

$0.00

$0

D/D

20,000

31,875

-

Brown Michael S

Director

– • –

2011-04-18

4

AS

$49.00

$245,000

D/D

(5,000)

14,662

-

SVP Res and Dev Sciences

• – –

2011-04-05

4

AS

$45.83

$1,572,656

D/D

(34,115)

50,350

-

Chairman of the Board

• • –

2011-04-04

4

GD

$0.00

$0

I/I

4,954

178,854

-

SVP Res and Dev Sciences

• – –

2011-04-04

4

D

$45.53

$2,649,527

D/D

(58,193)

84,465

-

SVP Res and Dev Sciences

• – –

2011-04-04

4

OE

$13.00

$1,200,004

D/D

92,308

142,658

-

Brown Michael S

Director

– • –

2011-03-31

4

AS

$44.65

$147,747

D/D

(3,309)

19,662

-

2433 Records found	Previous 70 71 72 73 74 75 76 77 78 79 Next	Page 76 of 98

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.